table of content
1 Study Coverage
1.1 Therapeutic Vaccines Product Introduction
1.2 Global Therapeutic Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Therapeutic Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Therapeutic Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Therapeutic Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Therapeutic Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Therapeutic Vaccines Sales in Volume for the Year 2017-2028
1.4 Therapeutic Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Therapeutic Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Therapeutic Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Therapeutic Vaccines Market Dynamics
1.5.1 Therapeutic Vaccines Industry Trends
1.5.2 Therapeutic Vaccines Market Drivers
1.5.3 Therapeutic Vaccines Market Challenges
1.5.4 Therapeutic Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Therapeutic Vaccines Market Segment by Type
2.1.1 Peptide Therapeutic Vaccine
2.1.2 Cell Therapeutic Vaccine
2.1.3 Nucleic Acid Therapeutic Vaccine
2.2 Global Therapeutic Vaccines Market Size by Type
2.2.1 Global Therapeutic Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Therapeutic Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Therapeutic Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Therapeutic Vaccines Market Size by Type
2.3.1 United States Therapeutic Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Therapeutic Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Therapeutic Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Therapeutic Vaccines Market Segment by Application
3.1.1 Oncotherapy
3.1.2 Hepatitis B
3.1.3 Tuberculosis
3.1.4 Herpes Simplex Virus
3.1.5 Others
3.2 Global Therapeutic Vaccines Market Size by Application
3.2.1 Global Therapeutic Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Therapeutic Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Therapeutic Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Therapeutic Vaccines Market Size by Application
3.3.1 United States Therapeutic Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Therapeutic Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Therapeutic Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Therapeutic Vaccines Competitor Landscape by Company
4.1 Global Therapeutic Vaccines Market Size by Company
4.1.1 Top Global Therapeutic Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Therapeutic Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Therapeutic Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Therapeutic Vaccines Price by Manufacturer (2017-2022)
4.2 Global Therapeutic Vaccines Concentration Ratio (CR)
4.2.1 Therapeutic Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Therapeutic Vaccines in 2021
4.2.3 Global Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Therapeutic Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Therapeutic Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Therapeutic Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Therapeutic Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Therapeutic Vaccines Market Size by Company
4.5.1 Top Therapeutic Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Therapeutic Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Therapeutic Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Therapeutic Vaccines Market Size by Region
5.1 Global Therapeutic Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Therapeutic Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Therapeutic Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Therapeutic Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Therapeutic Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Therapeutic Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Therapeutic Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Therapeutic Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Therapeutic Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Therapeutic Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Therapeutic Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Therapeutic Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Therapeutic Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Therapeutic Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Therapeutic Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Therapeutic Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Northeast Biotherapeutics
7.1.1 Northeast Biotherapeutics Corporation Information
7.1.2 Northeast Biotherapeutics Description and Business Overview
7.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Northeast Biotherapeutics Therapeutic Vaccines Products Offered
7.1.5 Northeast Biotherapeutics Recent Development
7.2 Agenus
7.2.1 Agenus Corporation Information
7.2.2 Agenus Description and Business Overview
7.2.3 Agenus Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Agenus Therapeutic Vaccines Products Offered
7.2.5 Agenus Recent Development
7.3 Vaccinogen Inc
7.3.1 Vaccinogen Inc Corporation Information
7.3.2 Vaccinogen Inc Description and Business Overview
7.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Vaccinogen Inc Therapeutic Vaccines Products Offered
7.3.5 Vaccinogen Inc Recent Development
7.4 CIMAB S.A
7.4.1 CIMAB S.A Corporation Information
7.4.2 CIMAB S.A Description and Business Overview
7.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 CIMAB S.A Therapeutic Vaccines Products Offered
7.4.5 CIMAB S.A Recent Development
7.5 Dendreon
7.5.1 Dendreon Corporation Information
7.5.2 Dendreon Description and Business Overview
7.5.3 Dendreon Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Dendreon Therapeutic Vaccines Products Offered
7.5.5 Dendreon Recent Development
7.6 Corixa
7.6.1 Corixa Corporation Information
7.6.2 Corixa Description and Business Overview
7.6.3 Corixa Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Corixa Therapeutic Vaccines Products Offered
7.6.5 Corixa Recent Development
7.7 AVAX Technologies
7.7.1 AVAX Technologies Corporation Information
7.7.2 AVAX Technologies Description and Business Overview
7.7.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 AVAX Technologies Therapeutic Vaccines Products Offered
7.7.5 AVAX Technologies Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Therapeutic Vaccines Industry Chain Analysis
8.2 Therapeutic Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Therapeutic Vaccines Distributors
8.3 Therapeutic Vaccines Production Mode & Process
8.4 Therapeutic Vaccines Sales and Marketing
8.4.1 Therapeutic Vaccines Sales Channels
8.4.2 Therapeutic Vaccines Distributors
8.5 Therapeutic Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
